Segawa Y - Search Results

1

Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients.

Takigawa N, Segawa Y, Maeda Y, Takata I, Fujimoto N. Takigawa N, et al. Among authors: segawa y. Lung Cancer. 1997 Jul;17(2-3):211-8. doi: 10.1016/s0169-5002(97)00651-x. Lung Cancer. 1997. PMID: 9237156

2

Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group.

Umemura S, Tsubouchi K, Yoshioka H, Hotta K, Takigawa N, Fujiwara K, Horita N, Segawa Y, Hamada N, Takata I, Yamane H, Kamei H, Kiura K, Tanimoto M. Umemura S, et al. Among authors: segawa y. Lung Cancer. 2012 Jul;77(1):134-9. doi: 10.1016/j.lungcan.2012.03.002. Epub 2012 Apr 7. Lung Cancer. 2012. PMID: 22487432

3

Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation.

Takigawa N, Segawa Y, Okahara M, Maeda Y, Takata I, Kataoka M, Fujii M. Takigawa N, et al. Among authors: segawa y. Lung Cancer. 1996 Aug;15(1):67-77. doi: 10.1016/0169-5002(96)00571-5. Lung Cancer. 1996. PMID: 8865124

4

Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.

Maeda Y, Segawa Y, Takigawa N, Takata I, Fujimoto N. Maeda Y, et al. Among authors: segawa y. Intern Med. 1996 Oct;35(10):764-71. doi: 10.2169/internalmedicine.35.764. Intern Med. 1996. PMID: 8933183 Free article.

5

Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation.

Segawa Y, Takigawa N, Mandai K, Maeda Y, Takata I, Fujimoto N, Jinno K. Segawa Y, et al. Lung Cancer. 1997 Mar;16(2-3):229-38. doi: 10.1016/s0169-5002(97)82785-7. Lung Cancer. 1997. PMID: 9152954

6

Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.

Takigawa N, Segawa Y, Mandai K, Takata I, Fujimoto N. Takigawa N, et al. Among authors: segawa y. Lung Cancer. 1997 Oct;18(2):147-57. doi: 10.1016/s0169-5002(97)00060-3. Lung Cancer. 1997. PMID: 9316006

7

Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.

Takigawa N, Segawa Y, Fujimoto N, Hotta K, Eguchi K. Takigawa N, et al. Among authors: segawa y. Anticancer Res. 1998 Mar-Apr;18(2B):1251-4. Anticancer Res. 1998. PMID: 9615796

8

Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.

Segawa Y, Kageyama M, Suzuki S, Jinno K, Takigawa N, Fujimoto N, Hotta K, Eguchi K. Segawa Y, et al. Br J Cancer. 1998 Sep;78(5):667-72. doi: 10.1038/bjc.1998.557. Br J Cancer. 1998. PMID: 9744508 Free PMC article.

9

Clinical investigation of atypical adenomatous hyperplasia of the lung.

Takigawa N, Segawa Y, Nakata M, Saeki H, Mandai K, Kishino D, Shimono M, Ida M, Eguchi K. Takigawa N, et al. Among authors: segawa y. Lung Cancer. 1999 Aug;25(2):115-21. doi: 10.1016/s0169-5002(99)00055-0. Lung Cancer. 1999. PMID: 10470845

10

Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.

Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K. Hotta K, et al. Among authors: segawa y. Anticancer Res. 2000 May-Jun;20(3B):2177-80. Anticancer Res. 2000. PMID: 10928173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters